James Huang's Net Worth

-$6.71 Million

Estimate Recalculated Jun 10, 2024 04:02PM EST

Who is James Huang?

James Huang does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Alaunos Therapeutics, Inc., Orion Biotech Opportunities Corp., WINDTREE THERAPEUTICS INC /DE/, and CASI Pharmaceuticals, Inc..

SEC CIK

James Huang's CIK is 0001573160

Past Insider Trading and Trends

2022 was James Huang's most active year for acquiring shares with 18 total transactions. James Huang's most active month to acquire stocks was the month of May. 2023 was James Huang's most active year for disposing of shares, totalling 6 transactions. James Huang's most active month to dispose stocks was the month of January. 2019 saw James Huang paying a total of $5,081,248.19 for 2,719,546 shares, this is the most they've acquired in one year. In 2023 James Huang cashed out on 7,104,615 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Alaunos Therapeutics, Inc. (TCRT) Snapshot price: $2.1

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 6
Form 4
+73.85%
80K
—
—
188.33K
Jun 22
Form 4
+73.85%
80K
—
—
188.33K
Jun 22
Form 4
+1,200.05%
100K
$1.71
$171,000.00
108.33K
Sep 1
Form 4
∞
8.33K
—
—
8.33K
Mar 4
Form 4
—
0
—
—
0
Jul 20
Form 3
—
0
—
—
0
No matching records found

Orion Biotech Opportunities Corp. No price found

Chief Executive Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 17
Form 3
—
0
—
—
0
No matching records found

WINDTREE THERAPEUTICS INC /DE/ (WINT) Snapshot price: $0.36

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+47.60%
1.11M
$0.14
$156,946.66
3.45M
Feb 22
Form 4
+1.72%
5K
—
—
296.28K
Jun 7
Form 4
+20.72%
50K
$1.90
$95,135.00
291.28K
Oct 19
Form 4
—
0
—
—
0
Jun 15
Form 4
+714.29%
150K
$2.36
$354,000.00
171K
Mar 31
Form 4
—
0
—
—
0
Feb 3
Form 4
+5.00%
1K
$6.67
$6,666.00
21K
Oct 23
Form 4/A
+150.00%
12K
$7.32
$87,867.60
20K
Jun 4
Form 4
+158.97%
12.4K
$7.32
$90,816.04
20.2K
Jun 3 - Jun 4
Form 4
+13.38%
275.86K
$7.25
$1,999,999.50
2.34M
May 22
Form 4
+1.74%
400
$3.84
$1,535.00
23.4K
Feb 18
Form 4
+2.22%
500
$4.05
$2,025.00
23K
Feb 7
Form 4
+10.07%
2.06K
$4.18
$8,609.40
22.5K
Jan 16 - Jan 17
Form 4
+308.84%
15.44K
$4.05
$62,524.66
20.44K
Dec 31
Form 4
∞
5K
$3.74
$18,723.95
5K
Dec 27 - Dec 30
Form 4
+37.75%
1.75M
$3.02
$4,999,999.58
6.39M
Dec 6
Form 4
—
0
—
—
0
Apr 24
Form 3
—
0
—
—
0
No matching records found

CASI Pharmaceuticals, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+17.59%
55.57K
$4.13
$229,661.84
371.52K
Sep 6 - Sep 8
Form 4
+13.34%
37.2K
$3.74
$139,036.30
315.94K
Aug 31 - Sep 2
Form 4
+19.01%
44.53K
$3.75
$166,929.82
278.75K
Aug 24 - Aug 26
Form 4
∞
234.22K
$3.33
$779,476.68
234.22K
Aug 19 - Aug 23
Form 4
—
0
—
—
0
May 25
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
Jun 20
Form 4
—
0
—
—
0
Jun 29
Form 4
-99.95%
-416.48K
—
—
191
Apr 4
Form 4
—
0
—
—
0
Jun 8
Form 4
—
0
—
—
0
Mar 2
Form 4
—
0
—
—
0
Apr 6
Form 4
—
0
—
—
0
Apr 3
Form 4
—
0
—
—
0
Apr 3
Form 4
—
0
—
—
0
May 30
Form 3
—
0
—
—
0
No matching records found